Gene · 134864
Papers1,472
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,472
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Thymosin α1 Elevates Lymphocyte Counts and Improves Immunoradiotherapy Outcomes in Patients with Advanced Cancer. | Cancer Manag Res | 2025 | 41293232 | PubTator, text mining | PubMed |
| Progress of AI-Driven Drug-Target Interaction Prediction and Lead Optimization. | Int J Mol Sci | 2025 | 41155330 | PubTator, text mining | PubMed |
| JP-14: A Trace Amine-Associated Receptor 1 Agonist with Anti-Metabolic Disorder Potential. | Int J Mol Sci | 2025 | 41155326 | PubTator, text mining | PubMed |
| Trace Amine-associated Receptors (TAARs): Candidate Targets in the Treatment of Bipolar Disorders. | Actas Esp Psiquiatr | 2025 | 41117250 | PubTator, text mining | PubMed |
| Hybrid BAG-seq: DNA and RNA from the same single nucleus reveals interactions between genomic and transcriptomic landscapes in human tumor samples. | Genome Biol | 2025 | 41015771 | PubTator, text mining | PubMed |
| Chemosensation of the pheromone spermine by the olfactory TAAR-like receptor TAAR348. | Cell Discov | 2025 | 41015618 | PubTator, text mining | PubMed |
| The Triplex-Centric Assembly and Maturation of the Herpesvirus Procapsid. | Viruses | 2025 | 41012581 | PubTator, text mining | PubMed |
| Multidimensional Evaluation of Lisdexamfetamine: Pharmacology, Therapeutic Use, Toxicity and Forensic Implications. | Basic Clin Pharmacol Toxicol | 2025 | 41001763 | PubTator, text mining | PubMed |
| β2AR as a target in methamphetamine addiction: Divergent mechanisms from TAAR1. | Cell Rep | 2025 | 40991929 | PubTator, text mining | PubMed |
| Efficacy of thymosin α1 for sepsis: a systematic review and meta-analysis of randomized controlled trials. | Front Cell Infect Microbiol | 2025 | 40969554 | PubTator, text mining | PubMed |
| The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets. | Onco Targets Ther | 2025 | 40955371 | PubTator, text mining | PubMed |
| NEuroMOrphic Neural-Response Decoding System for Adaptive and Personalized Neuro-Prosthetics' Control. | Biomimetics (Basel) | 2025 | 40862891 | PubTator, text mining | PubMed |
| Identification and Functional Analysis of WOX Genes in Macadamia spp. Reveal WOX1 and WOX4 Homologs Involved in Shoot Regeneration. | Physiol Plant | 2025 | 40842080 | PubTator, text mining | PubMed |
| Trace amine-associated receptor 1 agonists differentially regulate dopamine transporter function. | Mol Pharmacol | 2025 | 40840012 | PubTator, text mining | PubMed |
| Role of Glial Trace Amine Associated Receptor 1 (TAAR1) and Microbiota in Schizophrenia. | Neurochem Res | 2025 | 40839091 | PubTator, text mining | PubMed |
| Exploring the differences in mortality and its associated factors among young-old and old-old COVID-19 patients. | Front Med (Lausanne) | 2025 | 40809415 | PubTator, text mining | PubMed |
| A preliminary analysis of integrating thymosin α1 into concurrent chemoradiotherapy and consolidative immunotherapy in unresectable locally advanced non-small cell lung cancer. | Transl Lung Cancer Res | 2025 | 40799433 | PubTator, text mining | PubMed |
| Structure-based identification of bioactive compounds as trace amine-associated receptor 1 agonists for the therapeutic management of major depressive disorder. | PLoS One | 2025 | 40763190 | PubTator, text mining | PubMed |
| Exploration of current situation of psychotropic drugs research and development in China based on drug clinical trials. | Front Psychiatry | 2025 | 40735218 | PubTator, text mining | PubMed |
| Interferon-α and thymosin-α1 plus tislelizumab enhance CD8+ T cell cytotoxicity toward pancreatic ductal adenocarcinoma. | iScience | 2025 | 40727936 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/134864/papers?page=4